by Clare Gerrard | Nov 4, 2024
UK Government announces commitment to a National Cancer Strategy for England Several weeks ago, Neuroendocrine Cancer UK, and fellow charities, co-signed the joint One Cancer Voice letter to the Secretary of State for Health and Social Care, Wes Streeting,...
by Clare Gerrard | Aug 30, 2023
Problems obtaining travel insurance for people living with cancer: 4-minute Survey for Cancer patients. Please complete by Friday 22nd September 2023 PLANETS Cancer Charity (alongside Cancer52) would like to invite you to take this survey about your experience as a...
by Leanne Talbot | Jul 18, 2023
Last year, Neuroendocrine Cancer UK’s Patient Support Co-ordinator, and neuroendocrine cancer patient, Kate, gave a presentation to Ipsen, the manufacturer of Lanreotide, a monthly Somatostatin Analogue prescribed to many members of our patient community. The...
by Clare Gerrard | Jul 10, 2023
Review of Carcinoid Syndrome: what is is and how it is treated by Joel George et al (Hampshire Hospitals and Kings Healthcare Partners ENETs Centre of Excellence) Online Publication Date: 19 Jun 2023 Neuroendocrine Cancers (aka neuroendocrine neoplasms or NENs) may...
by Clare Gerrard | Apr 26, 2023
Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012 & 2018: A Retrospective, Population-Based Study : published 20th March 2023. A retrospective, population-based study comparing overall survival (OS) between males and females with...